Hyundai Bioscience

048410.KQ

8.08 USD

0.02

+0.25%

Overview

Last close

8.08 usd

Market cap

387.86M usd

52 week high

19.07 usd

52 week low

6.67 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

49.2344

Price/Book Value

4.486

Enterprise Value

347.02M usd

EV/Revenue

44.0185

EV/EBITDA

-64.6317

Key financials

Revenue TTM

7.88M usd

Gross Profit TTM

6.76M usd

EBITDA TTM

-2.90M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

96.62M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.